SE8600998L - Parenterala fenytoinpreparat - Google Patents

Parenterala fenytoinpreparat

Info

Publication number
SE8600998L
SE8600998L SE8600998A SE8600998A SE8600998L SE 8600998 L SE8600998 L SE 8600998L SE 8600998 A SE8600998 A SE 8600998A SE 8600998 A SE8600998 A SE 8600998A SE 8600998 L SE8600998 L SE 8600998L
Authority
SE
Sweden
Prior art keywords
phenytoin
parenteral
preparation
preparations
sodium
Prior art date
Application number
SE8600998A
Other languages
Unknown language ( )
English (en)
Other versions
SE8600998D0 (sv
Inventor
M B Fawzi
A K Taylor
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SE8600998D0 publication Critical patent/SE8600998D0/sv
Publication of SE8600998L publication Critical patent/SE8600998L/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8600998A 1985-05-20 1986-03-05 Parenterala fenytoinpreparat SE8600998L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/735,932 US4642316A (en) 1985-05-20 1985-05-20 Parenteral phenytoin preparations

Publications (2)

Publication Number Publication Date
SE8600998D0 SE8600998D0 (sv) 1986-03-05
SE8600998L true SE8600998L (sv) 1986-11-21

Family

ID=24957819

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8600998A SE8600998L (sv) 1985-05-20 1986-03-05 Parenterala fenytoinpreparat

Country Status (18)

Country Link
US (1) US4642316A (sv)
JP (1) JPS61268618A (sv)
AU (1) AU595790B2 (sv)
BE (1) BE904476A (sv)
CA (1) CA1268119A (sv)
CH (1) CH668594A5 (sv)
DE (1) DE3610330A1 (sv)
DK (1) DK100786A (sv)
ES (1) ES8707195A1 (sv)
FR (1) FR2581871B1 (sv)
GB (1) GB2175203B (sv)
IT (1) IT1190282B (sv)
LU (1) LU86383A1 (sv)
NL (1) NL8600899A (sv)
NZ (1) NZ215783A (sv)
PH (1) PH22922A (sv)
SE (1) SE8600998L (sv)
ZA (1) ZA862094B (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3828156A1 (de) * 1988-08-19 1990-02-22 Astrapin Pharmazeutische Praep Stabile waessrige loesung von fluorouracil
AU8479998A (en) * 1997-07-22 1999-02-16 Warner-Lambert Company Lyophilized fosphenytoin sodium for parenteral use
AU1917899A (en) 1998-03-20 1999-10-18 Warner-Lambert Company Crystalline sodium phenytoin monohydrate
US6274168B1 (en) 1999-02-23 2001-08-14 Mylan Pharmaceuticals Inc. Phenytoin sodium pharmaceutical compositions
US20060222713A1 (en) * 2002-12-16 2006-10-05 Deepak Murpani Extended release pharmaceutical composition of phenytoin sodium
EP2946810A1 (en) 2005-02-03 2015-11-25 TopoTarget UK Limited Combination therapy using an HDAC inhibitor and Vincristine for treating cancer
DE102005019393A1 (de) * 2005-04-25 2006-10-26 Basell Polyolefine Gmbh Polyethylenformmassen für Spritzgussanwendungen
SI1901729T1 (sl) * 2005-05-13 2012-05-31 Topotarget Uk Ltd Farmacevtske formulacije HDAC inhibitorjev
AU2012213940B2 (en) * 2005-05-13 2015-03-26 Topotarget Uk Limited Pharmaceutical formulations of HDAC inhibitors
WO2007054719A2 (en) 2005-11-10 2007-05-18 Topotarget Uk Limited Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer alone or in combination with chemotherapeutic agent
CA2812968A1 (en) * 2005-12-05 2007-06-14 Taro Pharmaceuticals North America, Inc. Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
CA2700173C (en) * 2007-09-25 2016-10-11 Topotarget Uk Limited Methods of synthesis of certain hydroxamic acid compounds
DK2262493T3 (en) * 2008-03-07 2015-04-27 Onxeo Dk Branch Of Onxeo S A France METHODS OF TREATMENT WITH prolonged continuous infusion of Belinostat
GB0900555D0 (en) * 2009-01-14 2009-02-11 Topotarget As New methods
KR101709904B1 (ko) * 2009-05-19 2017-02-23 뉴로덤 엘티디 Dopa 데카르복실라제 억제제의 연속투여용 조성물
HUE047841T2 (hu) 2010-11-15 2020-05-28 Neuroderm Ltd L-dopa, dopa dekarboxiláz inhibitorok, katekol-o-metil transzferáz inhibitorok folyamatos adagolására szolgáló készítmények
WO2012082995A1 (en) 2010-12-15 2012-06-21 Nektar Therapeutics Oligomer-containing hydantoin compounds
TR201903492T4 (tr) 2012-06-05 2019-04-22 Neuroderm Ltd Apomorfin ve organik asitler içeren bileşimler ve bunların kullanım alanları.
HUE064818T2 (hu) 2014-03-13 2024-04-28 Neuroderm Ltd Dopa dekarboxiláz inhibitor készítmények
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
WO2023205615A1 (en) * 2022-04-18 2023-10-26 ISHA Therapeutics LLC Orally dissolving antimicrobial film compositions & methods of their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3749779A (en) * 1970-08-27 1973-07-31 American Home Prod Stable solutions of sodium diphenylhydantoin
JPS5221575B2 (sv) * 1972-03-18 1977-06-11
US4260769A (en) * 1977-04-22 1981-04-07 Interx Research Corporation 5,5-Diphenylhydantoins
US4163058A (en) * 1977-04-22 1979-07-31 Interx Research Corporation Derivatives of 5,5-diphenylhydantoin exhibiting enhanced solubility and the therapeutic use thereof

Also Published As

Publication number Publication date
PH22922A (en) 1989-01-24
ES8707195A1 (es) 1987-07-16
JPS61268618A (ja) 1986-11-28
DK100786D0 (da) 1986-03-05
AU595790B2 (en) 1990-04-12
AU5441286A (en) 1986-11-27
IT8647936A0 (it) 1986-04-24
GB2175203A (en) 1986-11-26
BE904476A (fr) 1986-09-24
LU86383A1 (fr) 1986-09-02
FR2581871B1 (fr) 1990-05-11
GB2175203B (en) 1988-09-14
GB8607383D0 (en) 1986-04-30
CA1268119A (en) 1990-04-24
ES555143A0 (es) 1987-07-16
ZA862094B (en) 1986-11-26
SE8600998D0 (sv) 1986-03-05
DK100786A (da) 1986-11-21
CH668594A5 (fr) 1989-01-13
FR2581871A1 (fr) 1986-11-21
DE3610330A1 (de) 1986-11-20
US4642316A (en) 1987-02-10
NZ215783A (en) 1989-01-27
NL8600899A (nl) 1986-12-16
IT1190282B (it) 1988-02-16

Similar Documents

Publication Publication Date Title
SE8600998L (sv) Parenterala fenytoinpreparat
DK664187A (da) Hydrosolpraeparater
DK18088A (da) Taetningsarrangement
DE3766958D1 (de) Isochinolin-derivate.
DE3671372D1 (de) Etoposid-praeparate.
DK149988D0 (da) Stabile farmaceutiske praeparater
DK413987D0 (da) Farmaceutiske praeparater
SE8700203D0 (sv) Pyroglutamide derivatives
DK133786D0 (da) Praeparater
DK652787A (da) Farmaceutiske praeparater
IT1213467B (it) Procedimento di preparazione di monosialoganglioside.
DK111686D0 (da) Gelholdige farmaceutiske praeparater
DK401387D0 (da) Benzopyranderivatholdige praeparater
DK24986A (da) Allergenholdige praeparater
DK396986A (da) Parenterale phenytoin-praeparater
DK447887A (da) Frysetoerrede farmaceutiske praeparater
DK335587D0 (da) Vaeskefremmende veterinaerpraeparater
DK145688D0 (da) Skydelaas
DK416386D0 (da) Dobbeltvirkende roereorgan
DK92287D0 (da) Drivstangsbeslag
IT8721014A0 (it) 1-metansolfonilossi-6-trifluorometi l-1h-benzotriazolo e il suo impiego per preparare derivati della cefalosporina.
DK503386D0 (da) Peptidpraeparater
DK553487D0 (da) Baerbar projektoer
IT1206796B (it) 6-trifluorometil-1h-benzotriazol-1ile-difenilfosfato e il suo impiego per preparare derivati della cefaloscporina.
DK466086D0 (da) Exogent syrnede antacidiumpraeparater

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8600998-2

Effective date: 19921001

Format of ref document f/p: F